The EuroMyositis registry: an international collaborative tool to facilitate myositis research
- PMID: 28855174
- PMCID: PMC5754739
- DOI: 10.1136/annrheumdis-2017-211868
The EuroMyositis registry: an international collaborative tool to facilitate myositis research
Abstract
Aims: The EuroMyositis Registry facilitates collaboration across the idiopathic inflammatory myopathy (IIM) research community. This inaugural report examines pooled Registry data.
Methods: Cross-sectional analysis of IIM cases from 11 countries was performed. Associations between clinical subtypes, extramuscular involvement, environmental exposures and medications were investigated.
Results: Of 3067 IIM cases, 69% were female. The most common IIM subtype was dermatomyositis (DM) (31%). Smoking was more frequent in connective tissue disease overlap cases (45%, OR 1.44, 95% CI 1.09 to 1.90, p=0.012). Smoking was associated with interstitial lung disease (ILD) (OR 1.32, 95% CI 1.06 to 1.65, p=0.013), dysphagia (OR 1.43, 95% CI 1.16 to 1.77, p=0.001), malignancy ever (OR 1.78, 95% CI 1.36 to 2.33, p<0.001) and cardiac involvement (OR 2.40, 95% CI 1.60 to 3.60, p<0.001).Dysphagia occurred in 39% and cardiac involvement in 9%; either occurrence was associated with higher Health Assessment Questionnaire (HAQ) scores (adjusted OR 1.79, 95% CI 1.43 to 2.23, p<0.001). HAQ scores were also higher in inclusion body myositis cases (adjusted OR 3.85, 95% CI 2.52 to 5.90, p<0.001). Malignancy (ever) occurred in 13%, most commonly in DM (20%, OR 2.06, 95% CI 1.65 to 2.57, p<0.001).ILD occurred in 30%, most frequently in antisynthetase syndrome (71%, OR 10.7, 95% CI 8.6 to 13.4, p<0.001). Rash characteristics differed between adult-onset and juvenile-onset DM cases ('V' sign: 56% DM vs 16% juvenile-DM, OR 0.16, 95% CI 0.07 to 0.36, p<0.001). Glucocorticoids were used in 98% of cases, methotrexate in 71% and azathioprine in 51%.
Conclusion: This large multicentre cohort demonstrates the importance of extramuscular involvement in patients with IIM, its association with smoking and its influence on disease severity. Our findings emphasise that IIM is a multisystem inflammatory disease and will help inform prognosis and clinical management of patients.
Keywords: Disease registries; Myositis.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Conflict of interest statement
Competing interests: None declared.
Figures
Comment in
-
Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria.Ann Rheum Dis. 2018 Aug;77(8):e50. doi: 10.1136/annrheumdis-2017-212368. Epub 2017 Sep 25. Ann Rheum Dis. 2018. PMID: 28970214 No abstract available.
-
Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna et al.Ann Rheum Dis. 2018 Aug;77(8):e51. doi: 10.1136/annrheumdis-2017-212382. Epub 2017 Dec 19. Ann Rheum Dis. 2018. PMID: 29259048 No abstract available.
References
Publication types
MeSH terms
Grants and funding
- 18475/VAC_/Versus Arthritis/United Kingdom
- G0900753/MRC_/Medical Research Council/United Kingdom
- 18474/ARC_/Arthritis Research UK/United Kingdom
- 20639/VAC_/Versus Arthritis/United Kingdom
- MR/K002279/1/MRC_/Medical Research Council/United Kingdom
- MR/N003322/1/MRC_/Medical Research Council/United Kingdom
- MR/P020941/1/MRC_/Medical Research Council/United Kingdom
- G0600237/MRC_/Medical Research Council/United Kingdom
- RC-PG-0407-10054/DH_/Department of Health/United Kingdom
- G0100594/MRC_/Medical Research Council/United Kingdom
- G0901461/MRC_/Medical Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical